schliessen

Filtern

 

Bibliotheken

Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer

The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in... Full description

Journal Title: PLoS ONE 01 January 2013, Vol.8(10), p.e77060
Main Author: Xinyu Wu
Other Authors: Yirong Li , Jinhua Wang , Xin Wen , Max T Marcus , Garrett Daniels , David Y Zhang , Fei Ye , Ling Hang Wang , Xinxin Du , Sylvia Adams , Baljit Singh , Jiri Zavadil , Peng Lee , Marie E Monaco
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0077060
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: doaj_soai_doaj_org_article_2c0f52787b634afda62d4237873d7cdc
title: Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
format: Article
creator:
  • Xinyu Wu
  • Yirong Li
  • Jinhua Wang
  • Xin Wen
  • Max T Marcus
  • Garrett Daniels
  • David Y Zhang
  • Fei Ye
  • Ling Hang Wang
  • Xinxin Du
  • Sylvia Adams
  • Baljit Singh
  • Jiri Zavadil
  • Peng Lee
  • Marie E Monaco
subjects:
  • Sciences (General)
ispartof: PLoS ONE, 01 January 2013, Vol.8(10), p.e77060
description: The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor α (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.
language: eng
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0077060
fulltext: fulltext_linktorsrc
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID1836646208
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidoai_doaj_org_article_2c0f52787b634afda62d4237873d7cdc
sourceiddoaj_s
recordidTN_doaj_soai_doaj_org_article_2c0f52787b634afda62d4237873d7cdc
sourcesystemOther
dbidDOA
pqid1445914083
galeid478272638
display
typearticle
titleLong chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
creatorXinyu Wu ; Yirong Li ; Jinhua Wang ; Xin Wen ; Max T Marcus ; Garrett Daniels ; David Y Zhang ; Fei Ye ; Ling Hang Wang ; Xinxin Du ; Sylvia Adams ; Baljit Singh ; Jiri Zavadil ; Peng Lee ; Marie E Monaco
ispartofPLoS ONE, 01 January 2013, Vol.8(10), p.e77060
identifierE-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0077060
subjectSciences (General)
descriptionThe purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor α (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.
languageeng
oafree_for_read
source
version8
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttps://doaj.org/article/2c0f52787b634afda62d4237873d7cdc$$EView_full_text_in_DOAJ
search
creatorcontrib
0Xinyu Wu
1Yirong Li
2Jinhua Wang
3Xin Wen
4Max T Marcus
5Garrett Daniels
6David Y Zhang
7Fei Ye
8Ling Hang Wang
9Xinxin Du
10Sylvia Adams
11Baljit Singh
12Jiri Zavadil
13Peng Lee
14Marie E Monaco
titleLong chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
description

The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor α (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.

subjectSciences (General)
general
0English
1Public Library of Science (PLoS)
210.1371/journal.pone.0077060
3Directory of Open Access Journals (DOAJ)
sourceiddoaj_s
recordiddoaj_soai_doaj_org_article_2c0f52787b634afda62d4237873d7cdc
issn
01932-6203
119326203
rsrctypearticle
creationdate2013
addtitlePLoS ONE
searchscope
0doaj_full
1doaj1
scope
0doaj_full
1doaj1
lsr45$$EView_full_text_in_DOAJ
tmp01Directory of Open Access Journals (DOAJ)
tmp02DOA
startdate20130101
enddate20130101
lsr40PLoS ONE, 01 January 2013, Vol.8 (10), p.e77060
doi10.1371/journal.pone.0077060
citationpf e77060 vol 8 issue 10
lsr30VSR-Enriched:[pages, galeid, pqid]
sort
titleLong chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
authorXinyu Wu ; Yirong Li ; Jinhua Wang ; Xin Wen ; Max T Marcus ; Garrett Daniels ; David Y Zhang ; Fei Ye ; Ling Hang Wang ; Xinxin Du ; Sylvia Adams ; Baljit Singh ; Jiri Zavadil ; Peng Lee ; Marie E Monaco
creationdate20130101
lso0120130101
facets
frbrgroupid6390125533976176434
frbrtype5
newrecords20190714
languageeng
topicSciences (General)
collectionDirectory of Open Access Journals (DOAJ)
prefilterarticles
rsrctypearticles
creatorcontrib
0Xinyu Wu
1Yirong Li
2Jinhua Wang
3Xin Wen
4Max T Marcus
5Garrett Daniels
6David Y Zhang
7Fei Ye
8Ling Hang Wang
9Xinxin Du
10Sylvia Adams
11Baljit Singh
12Jiri Zavadil
13Peng Lee
14Marie E Monaco
jtitlePLoS ONE
creationdate2013
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
au
0Xinyu Wu
1Yirong Li
2Jinhua Wang
3Xin Wen
4Max T Marcus
5Garrett Daniels
6David Y Zhang
7Fei Ye
8Ling Hang Wang
9Xinxin Du
10Sylvia Adams
11Baljit Singh
12Jiri Zavadil
13Peng Lee
14Marie E Monaco
atitleLong chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
jtitlePLoS ONE
risdate20130101
volume8
issue10
spagee77060
eissn1932-6203
formatjournal
genrearticle
ristypeJOUR
abstract

The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor α (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.

pubPublic Library of Science (PLoS)
doi10.1371/journal.pone.0077060
urlhttps://doaj.org/article/2c0f52787b634afda62d4237873d7cdc
lad01PLoS ONE
oafree_for_read
pagese77060
date2013-01-01